Analyst Report: Upgrade for access Securisyn’s Tech Saves Patients’ Lives and Hospitals’ Bottom Lines

Using Securisyn's medical technology, hospitals should be able to both save lives and make better profits.

Company: Securisyn Medical
Security Type: SAFE
Valuation: $40,000,000
Min Investment: $100
Platform: Republic
Deadline: Dec 31, 2022
Andy Gordon - December 27th, 2022

Archaic Technology

Note: This recommendation was co-authored by KingsCrowd Investment Research Analyst Teddy Lyons.

I prefer to stay as far away from hospitals as possible. 

Don’t get me wrong. I appreciate hospitals. But I also know that hospitals are businesses that are concerned with revenue and profit just like any other company. And that means that patient care is not always a top priority. This is America. We live in a capitalist, for-profit society. So I get it. But for some reason, knowing this about hospitals rubs me the wrong way.

I do give hospitals credit for having the most cutting-edge tools at their disposal, which is some consolation. That’s certainly true for imaging and surgical technology. 

But what if I told you that there is an area of patient care where practitioners use tape as the main source of stabilization? Can’t be, right?

Well, that is precisely the case when it comes to the stabilization of breathing tubes used to keep ventilated patients alive. Tape! Let that sink in. Because it’s as bad as it sounds. Tape is so unstable that unplanned extubation (the accidental removal of a breathing tube from an airway) is associated with 33,000 preventable deaths each year in the United States. 

The technology is archaic. In fact, it’s a joke. Somehow, no company has stepped forward to offer a product that can prevent the epidemic of endotracheal tube slippage and unplanned extubation. 

Until now.

The company I’m introducing to you today — Securisyn Medical — has patented a tube stabilization device that solves the life-threatening issues surrounding unplanned extubation and tube slippage. 

For hospitals, this is huge. Any opportunity to lower fatality rates is an obvious reason to purchase a product like SolidAIRity Flex, Securisyn’s flagship breathing stabilization product. 

And because the product never enters the body, Securisyn’s products do not need FDA approval. That’s a big investing risk off the table. 

Pay Annually - save 17%

This content requires: Edge

Data-driven startup investment ratings, AI analyst reports, and portfolio company exit and failure tracking

30 /month
25 /annually

What's included

  • Everything in Free plus
  • Data-driven investment ratings and AI analyst reports
  • Advanced company search table (with ratings and reports)
  • Markets page filters and historical industry data
  • Startup investment exit and failure tracker

Recent Analyst Reports

Analyst Report
Teeccino Is Ready for Explosive Growth

Teeccino Is Ready for Explosive Growth

Teeccino, a coffee alternative, has achieved product-market fit and is looking for explosive growth in the coming years.

Teddy Lyons Teddy Lyons

Teddy Lyons

Analyst Report
Zencastr Tackles Advertising and Monetization Problems for Podcasts

Zencastr Tackles Advertising and Monetization Problems for Podcasts

Zencastr, despite having just a few months of runway, has an impressive product that solves some major pain points for podcasters.

Olivia Strobl Olivia Strobl

Olivia Strobl

Analyst Report
Skillest Brings Golf Amateurs and Pros Together in the Best Way

Skillest Brings Golf Amateurs and Pros Together in the Best Way

Remote golf coaching app Skillest is attracting a growing population of golfers with enthusiastic coaches and free advertising.

Teddy Lyons Teddy Lyons

Teddy Lyons

Give your startup investing an edge by creating a free KingsCrowd account and getting started today.

Get a free weekly Pitch Review!

Sign up for our 3 minute newsletter with fresh takes on the top-rated investments and key startup trends you should know.

We care about the protection of your data. Read our Privacy Policy.